Crescita Therapeutics Inc.
CRRTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,393 | $6,233 | $3,537 | $6,902 |
| % Growth | -13.5% | 76.2% | -48.8% | – |
| Cost of Goods Sold | $2,538 | $2,408 | $1,790 | $3,907 |
| Gross Profit | $2,855 | $3,825 | $1,747 | $2,995 |
| % Margin | 52.9% | 61.4% | 49.4% | 43.4% |
| R&D Expenses | $138 | $141 | $131 | $156 |
| G&A Expenses | $0 | $2,748 | $0 | $0 |
| SG&A Expenses | $2,495 | $2,748 | $2,325 | $2,742 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $384 | $353 | $353 | $365 |
| Operating Expenses | $3,017 | $3,242 | $2,809 | $3,263 |
| Operating Income | -$162 | $583 | -$1,062 | -$268 |
| % Margin | -3% | 9.4% | -30% | -3.9% |
| Other Income/Exp. Net | $915 | $215 | $130 | $92 |
| Pre-Tax Income | $753 | $798 | -$932 | -$176 |
| Tax Expense | $0 | $0 | $0 | -$14 |
| Net Income | $753 | $798 | -$932 | -$162 |
| % Margin | 14% | 12.8% | -26.4% | -2.3% |
| EPS | 0.04 | 0.042 | -0.049 | -0.008 |
| % Growth | -5% | 185.9% | -483.3% | – |
| EPS Diluted | 0.04 | 0.04 | -0.05 | -0.008 |
| Weighted Avg Shares Out | 18,837 | 18,934 | 19,028 | 19,272 |
| Weighted Avg Shares Out Dil | 18,849 | 19,037 | 19,028 | 19,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | $38 | $131 | $100 | $134 |
| Interest Expense | $10 | $12 | $12 | $15 |
| Depreciation & Amortization | $384 | $353 | $353 | $365 |
| EBITDA | $1,147 | $1,163 | -$567 | $204 |
| % Margin | 21.3% | 18.7% | -16% | 3% |